minoxidil 2.5 MG Oral Tablet
INDICATIONS AND USAGE Because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. At the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. Minoxidil reduced supine diastolic blood pressure by 20 mm Hg or to 90 mm Hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs.
Actavis Pharma, Inc.
ROUND WHITE DAN 5642 2 5
DAN 5642 2 5 ROUND WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
MINOXIDIL Tablets, USP 2.5 mg are 9/32 ", scored, round, white tablets imprinted “ DAN 5642 ” and “ 2.5 ” supplied in bottles of 100 NDC 0591-5642-01 and 500 NDC 0591-5642-05.
MINOXIDIL Tablets, USP 10 mg are 9/32 ", scored, round, white tablets imprinted “ DAN 5643 ” and “ 10 ” supplied in bottles of 100 NDC 0591-5643-01 and 500 NDC 0591-5643-05. Dispense in a tight container with child-resistant closure. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense with Patient Package Insert available at: www.tevausa.com/PatientPI Manufactured In India By: Watson Pharma Private Limited Verna, Salcette Goa 403 722, India Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. B 2/2024
More pills like ROUND DAN 5642 2 5